Piper Jaffray analyst Sarah James raised her price target for UnitedHealth to $312 and increased her estimates following the company’s investor day. Management laid out a 10-year plan which includes a half trillion in revenue, lots more tech, and becoming the largest prescription delivery service that delivers within 1 hour of the script being written, James tells investors in a research note titled “The Future is UNH; Taking Up Numbers and Bullish on 10Y Outlook.” She believes the 10-year growth trajectory by segment reads bullish and continues to recommend adding to positions at these levels. James keeps an Overweight rating on UnitedHealth.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.